Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Triage and first 5 minutes
Instability screen
Hypotension
Systolic blood pressure under 90 mmHg
Shock index over 1
High risk pain pattern
Sudden severe abdominal pain
Sudden severe back or flank pain
Perfusion threat
Altered mental status
Cool mottled skin
Rupture concern
Syncope or near syncope
Rapid hemoglobin fall
Early parallel actions
Team activation
Vascular surgery or interventional radiology activation for rupture pathway
Anesthesia and operating room notification for high suspicion
Monitoring
Cardiac monitor
Continuous pulse oximetry
Vascular access
Two large bore peripheral IV
Rapid infuser availability
Bedside imaging
Point of care ultrasound aorta for immediate confirmation
If unstable and positive POCUS then rupture pathway without delay
Hemodynamic strategy
Permissive hypotension for suspected rupture
Conscious patient target
Systolic blood pressure 80 to 90 mmHg
Palpable radial pulse acceptable surrogate
Avoid over resuscitation
Minimize crystalloid
Early blood products for hemorrhagic shock
If profound shock
Norepinephrine infusion while blood products running
Escalate to massive transfusion protocol if ongoing instability
Airway and ventilation considerations
Intubation risk
Hemodynamic collapse with induction
Prepare push dose vasopressor
If intubation required
Minimize positive pressure ventilation until blood products started
Lowest effective PEEP
Time critical decision points
Diagnostic pathway choice
Hemodynamically unstable
POCUS positive AAA then immediate vascular surgery pathway
CT deferred if delays definitive hemorrhage control
Hemodynamically stable
CT angiography abdomen and pelvis for operative planning
Transfer decision if no endovascular capability
Key pitfalls
Normal blood pressure does not exclude rupture
Transient tamponade by retroperitoneum
Early presentation before decompensation
Absent palpable mass does not exclude AAA
Obesity
Small aneurysm rupture
Anchoring on renal colic
First episode flank pain in older smoker
Pain with syncope
History
Presentation patterns
Classic symptom complex
Pain
Abdominal
Back
Syncope
Collapse episode
Presyncope with diaphoresis
Hypotension
EMS low blood pressure
Transient response to fluids
Atypical presentations
Isolated flank pain
Mimics renal colic
Minimal abdominal tenderness
Isolated groin or hip pain
Iliac aneurysm involvement
Femoral neuropathy symptoms
Gastrointestinal symptoms
Nausea and vomiting
Early satiety from mass effect
Risk factors and triggers
Atherosclerotic risk
Smoking history
Current smoker
Prior heavy smoking
Hypertension
Longstanding
Poorly controlled
Hyperlipidemia
Prior statin use
Untreated dyslipidemia
Demographic risk
Age
Over 65 years
Over 75 years higher rupture risk
Sex
Male sex increased prevalence
Female sex higher rupture risk at smaller diameter
Familial and genetic risk
Family history
First degree relative with AAA
Family history of sudden death unclear cause
Connective tissue disease
Marfan syndrome
Ehlers Danlos syndrome
Symptom modifiers
Pain onset time
Sudden onset minutes
Progressive hours to days
Anticoagulant use
DOAC
Warfarin
Recent procedures
Recent vascular intervention
Recent abdominal surgery
Physical Exam
Hemodynamics and perfusion
Vital sign pattern
Hypotension
Systolic blood pressure under 90 mmHg
Narrow pulse pressure
Tachycardia
Heart rate over 100 beats per minute
Relative bradycardia possible in elderly or beta blocker use
Respiratory distress
Tachypnea
Hypoxia from shock
Shock exam
Skin perfusion
Cool clammy
Mottling
Mental status
Confusion
Lethargy
Abdominal and vascular exam
Abdominal findings
Tenderness
Diffuse
Left sided or periumbilical
Pulsatile mass
Palpable midline pulsation
Not reliably present
Peritonitis
Guarding
Rebound
Peripheral vascular assessment
Pulses
Diminished distal pulses
Asymmetric pulses with iliac involvement
Limb ischemia signs
Pallor
Pain with paresthesia
Neurologic complications
Lower extremity weakness
Spinal cord ischemia rare
Acute paraplegia rare
Femoral neuropathy
Anterior thigh pain
Quadriceps weakness
Differential Diagnosis
Life threatening mimics
Aortic syndromes
Aortic dissection
Chest pain with back pain
Pulse deficit
Thoracoabdominal aneurysm rupture
Chest to abdomen pain
Hypotension
Cardiac and vascular
Acute coronary syndrome
Epigastric pain
Diaphoresis
Massive pulmonary embolism
Syncope
Hypotension with hypoxia
Abdominal catastrophes
Mesenteric ischemia
Pain out of proportion
Elevated lactate
Perforated viscus
Peritonitis
Free air on imaging
Common mimics by symptom cluster
Flank pain predominant
Ureterolithiasis
Colicky pain waves
Hematuria
Pyelonephritis
Fever
CVA tenderness
Epigastric pain predominant
Pancreatitis
Lipase elevation
Alcohol or gallstone history
Peptic ulcer disease bleeding
Melena
Hypotension with anemia
Back pain predominant
Vertebral compression fracture
Trauma or osteoporosis
Focal spinal tenderness
Spinal epidural abscess
Fever
Neurologic deficits
Coding alignment
Abdominal aortic aneurysm concepts
ICD 10 CM abdominal aortic aneurysm without rupture I71.4
ICD 10 CM ruptured abdominal aortic aneurysm I71.3
Laboratory Tests
Hemorrhage and transfusion readiness
Hemorrhage evaluation
Complete blood count
Hemoglobin trend for bleeding severity
Platelet count for transfusion planning
Type and screen
Immediate availability of uncrossmatched blood if unstable
Crossmatch for operative planning
Coagulation profile
INR for warfarin effect
aPTT for heparin effect
Massive transfusion monitoring
Fibrinogen
Low fibrinogen marker of consumption
Cryoprecipitate threshold per local protocol
Ionized calcium
Citrate toxicity during transfusion
Calcium replacement guidance
Shock and end organ assessment
Perfusion markers
Lactate mmol per L
Elevated lactate supports shock physiology
Clearance trend for resuscitation response
Venous blood gas
Metabolic acidosis assessment
Elevated lactate correlation
Renal and metabolic baseline
Creatinine and electrolytes
Contrast planning for CT angiography
Baseline chronic kidney disease assessment
Glucose
Stress hyperglycemia
Hypoglycemia as alternative cause of altered mental status
Medication related labs
Anticoagulant specific considerations
INR
Warfarin reversal planning
Target normalization prior to surgery if feasible
Anti Xa level if available
Factor Xa inhibitor effect estimation
Reversal agent decision support
Diagnostic Tests
Scoring Systems
Prognostic scores for ruptured AAA
Hardman index
Age over 76 years
Creatinine over 190 micromol per L
Hemoglobin under 9 g per dL
Loss of consciousness
Ischemic ECG changes
Glasgow aneurysm score
Age component
Shock component
Myocardial disease component
Clinical application limits
Scores support counseling
Not for denying potentially life saving care
Use alongside surgical judgment
Score timing sensitivity
Prehospital physiology changes
Resuscitation alters variables
MRI
Limited role in acute AAA
Hemodynamic stability requirement
Not for unstable rupture
Prolonged acquisition time
Contrast considerations
Gadolinium caution in advanced kidney disease
Alternative when iodinated contrast contraindicated
Potential indications
Chronic contained rupture evaluation
Stable patient with equivocal CT
Soft tissue characterization
Inflammatory aneurysm assessment
Periaortic fibrosis evaluation
Adjacent organ involvement
CT
CT angiography abdomen pelvis
Indications
Stable patient with suspected symptomatic AAA
Preoperative planning for EVAR or open repair
Diagnostic performance
High sensitivity for aneurysm and rupture signs
High specificity for retroperitoneal hemorrhage localization
Protocol pearls
Arterial phase imaging for endograft planning
Iliac and femoral access vessel evaluation
CT signs of rupture or impending rupture
Retroperitoneal hematoma
Psoas hematoma
Perirenal stranding
Contrast extravasation
Active bleeding
Contained leak pattern
High attenuation crescent sign
Intramural hemorrhage
Higher rupture risk feature
Ultrasound
Point of care ultrasound aorta
Indications
Undifferentiated hypotension
Older patient with abdominal or back pain
Accuracy
High sensitivity for aneurysm detection when adequate windows
Limited ability to prove rupture
Technique essentials
Proximal to distal aorta sweep
Measure outer wall to outer wall in transverse view
Ultrasound pitfalls
Obesity and bowel gas
Poor windows false negative risk
Use CT if stable and suspicion persists
Iliac aneurysm missed
Distal aorta cutoff
Extend scan to iliac bifurcation when possible
Disposition
Rupture and symptomatic AAA
Ruptured AAA pathway
Immediate definitive care
Operating room or endovascular suite
Avoid delays for nonessential testing
Transfer criteria
No vascular surgery capability onsite
No endovascular capability when EVAR likely
Symptomatic intact AAA
Admission requirement
Pain attributed to aneurysm
Rapid aneurysm growth suspected
Urgency
Vascular surgery consult in ED
CT angiography for planning if stable
Incidental small AAA
Discharge eligibility
Asymptomatic
No aneurysm related pain
Stable vital signs
Reliable follow up
Primary care or vascular clinic referral
Surveillance imaging plan documented
Follow up timeframes
Size based surveillance
3.0 to 3.9 cm ultrasound every 3 years
4.0 to 4.9 cm ultrasound every 12 months
Larger aneurysm surveillance
5.0 to 5.4 cm ultrasound every 6 months
Vascular surgery evaluation recommended
Treatment
Resuscitation for suspected rupture
Hemorrhage control strategy
Damage control resuscitation
Early balanced transfusion
Packed red blood cells per massive transfusion protocol
Plasma per massive transfusion protocol
Platelets per massive transfusion protocol
Crystalloid minimization
Small bolus only if no blood immediately available
Stop crystalloid once blood products running
Permissive hypotension targets
Systolic blood pressure 80 to 90 mmHg
If altered mental status then higher target individualized
If traumatic brain injury concern then avoid hypotension
Vasopressor bridge when needed
Norepinephrine infusion
Initiate 0.05 microgram per kg per minute
Titrate every 2 to 5 minutes
Typical range 0.05 to 0.5 microgram per kg per minute
Goal
Maintain minimal perfusion until hemorrhage control
Avoid hypertension that increases bleeding
Analgesia and antiemesis
Opioid analgesia
Fentanyl IV
25 to 50 microgram bolus
Repeat every 5 to 10 minutes as needed
Monitor for hypotension and respiratory depression
Hydromorphone IV
0.2 to 0.5 mg bolus
Repeat every 10 to 15 minutes as needed
Reduced dose in older adults
Antiemetic options
Ondansetron IV
4 mg dose
Repeat once if needed
QT prolongation risk consideration
Metoclopramide IV
10 mg dose
Akathisia risk
Avoid in bowel obstruction concern
Anticoagulation reversal when emergent surgery likely
Warfarin reversal
Four factor prothrombin complex concentrate
Weight based dosing per institutional protocol
Higher dose for INR over 4
Lower dose for INR 2 to 4
Vitamin K IV
5 to 10 mg dose
Slower onset but sustains reversal
Factor Xa inhibitor reversal
Andexanet alfa when available
High dose regimen for recent high dose ingestion per protocol
Low dose regimen for lower exposure per protocol
Four factor prothrombin complex concentrate alternative
50 units per kg commonly used off label
Thrombosis risk monitoring
Definitive management coordination
Operative pathway selection
Endovascular aneurysm repair suitability
Adequate proximal neck anatomy on CT angiography
Adequate iliac access vessels
Open repair indications
Unfavorable anatomy for EVAR
Hemodynamic collapse with no endovascular option
Perioperative adjuncts
Antibiotic prophylaxis
Cefazolin IV per surgical protocol
Alternative for severe beta lactam allergy per protocol
Temperature management
Active warming
Prevent hypothermia related coagulopathy
Medical management for intact AAA and prevention
Cardiovascular risk reduction
Smoking cessation
Nicotine replacement options
Counseling and follow up plan
Statin therapy
High intensity statin for atherosclerotic risk
LDL reduction target per prevention guidelines
Blood pressure control
Antihypertensive adherence
Avoid severe uncontrolled hypertension
Surveillance and elective repair thresholds
Elective repair size thresholds
Men diameter 5.5 cm or greater
Women diameter 5.0 cm or greater
Growth thresholds
Expansion 0.5 cm or more in 6 months
Expansion 1.0 cm or more in 12 months
Special Populations
Pregnancy
Pregnancy considerations
Rare but catastrophic
Increased blood volume masking early shock
Maternal fetal mortality risk high with rupture
Imaging choices
Ultrasound preferred initial test
CT angiography if life threatening instability and planning required
Medication considerations
Avoid teratogenic antihypertensives when possible
Obstetrics consultation early
Geriatric
Older adult considerations
Atypical physiology
Relative bradycardia on beta blockers
Baseline low blood pressure
Comorbidity burden
Coronary disease increases perioperative risk
Chronic kidney disease affects contrast decisions
Frailty and goals of care
Rapid discussion with patient and family when feasible
Incorporate surgical risk and patient values
Pediatrics
Pediatric AAA considerations
Extremely rare
Congenital aneurysm
Connective tissue disorder
Etiology differences
Vasculitis
Infection mycotic aneurysm
Management differences
Pediatric vascular surgery consultation
Weight based medication dosing and blood product dosing
Background
Epidemiology
Population patterns
Age distribution
Prevalence increases after 65 years
Peak in older adults
Sex distribution
Higher prevalence in men
Higher rupture risk in women at smaller diameters
Smoking association
Strongest modifiable risk factor
Risk persists after cessation but decreases over time
Screening impact
One time ultrasound screening
Men 65 to 75 ever smoked benefit highest
Family history may justify broader screening
Mortality reduction
Elective repair prevents rupture deaths
Surveillance detects expansion
Pathophysiology
Aneurysm biology
Wall degeneration
Elastin breakdown
Collagen remodeling
Inflammation and proteolysis
Matrix metalloproteinase activity
Chronic inflammatory infiltrate
Hemodynamic stress
Increased wall tension with larger radius
Laplace relationship explains rupture risk rise with diameter
Rupture mechanism
Wall stress exceeds wall strength
Rapid expansion increases risk
Hypertension and acute stressors contribute
Contained rupture possibility
Retroperitoneal tamponade
Temporary stability before collapse
Therapeutic Considerations
EVAR versus open repair
EVAR advantages
Lower short term mortality in many cohorts
Shorter recovery time
EVAR limitations
Lifelong imaging surveillance for endoleak
Reintervention risk
Open repair advantages
Durable long term repair
Less long term device surveillance
Medical therapy limits
No proven medication to reverse AAA growth
Risk factor modification cornerstone
Surveillance imaging core strategy
Blood pressure management
Reduces overall cardiovascular risk
Unclear direct effect on aneurysm expansion
Patient Discharge Instructions
Copy discharge instructions
Abdominal aortic aneurysm follow up plan
Imaging surveillance schedule
Ultrasound timing provided based on aneurysm size
Vascular clinic referral if near repair threshold
Risk reduction actions
Stop smoking support resources
Take blood pressure and cholesterol medications as prescribed
Return to emergency care now
Rupture warning symptoms
Sudden severe abdominal pain
Sudden severe back or flank pain
Shock warning symptoms
Fainting or near fainting
New severe weakness or confusion
Limb ischemia symptoms
New cold painful leg
New numbness or weakness in a leg
Activity and medication guidance
Avoid heavy lifting until follow up if symptomatic or large aneurysm
Discuss safe limits with vascular team
Gradual return to activity when cleared
Medication safety
Do not stop anticoagulants without clinician guidance
Report any new bleeding concerns promptly
References
Clinical guidelines and society statements
Guideline sources
ACC AHA guideline for aortic disease
Screening and surveillance recommendations
Repair threshold recommendations
Society for Vascular Surgery clinical practice guidelines
Elective repair thresholds
Surveillance intervals
European Society for Vascular Surgery AAA guidelines
EVAR and open repair considerations
Rupture management principles
Evidence based sources and tools
Evidence anchors
Major randomized trials comparing EVAR and open repair in elective AAA
Short term outcomes comparisons
Long term reintervention considerations
Prognostic tools for ruptured AAA
Hardman index derivation and validation studies
Glasgow aneurysm score validation studies
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.